CIK 0001681087 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in NY · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Net income (USD) | -105.9 M | -119.1 M | ||
| Diluted EPS (USD/shares) | -4.05 | -33.76 | -2.42 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | 4 | 2026-09-25 |
| 2026-10-02 | 4 | 4 | 2026-09-25 |
| 2026-10-02 | 4 | 4 | 2026-09-25 |
| 2026-10-02 | 4 | 4 | 2026-09-25 |
| 2026-10-02 | 4 | 4 | 2026-09-25 |
| 2026-09-30 | 144 | 144 | |
| 2026-09-29 | 8-K | 8-K items 8.01,9.01 | 2026-09-29 |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-08-27 | 144 | 144 | |
| 2026-08-26 | 4 | 4 | 2026-08-25 |
| 2026-08-21 | 144 | 144 | |
| 2026-08-14 | 4 | 4 | 2026-08-12 |
| 2026-08-12 | 144 | 144 | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-06-30 | 144 | 144 | |
| 2026-06-23 | 4 | 4 | 2026-06-20 |
| 2026-06-12 | 4 | 4 | 2026-06-11 |
| 2026-06-10 | 8-K | 8-K items 5.07,8.01,9.01 | 2026-06-08 |
| 2026-06-10 | 4 | 4 | 2026-06-09 |
Forms on file (last 1,000): 4 183, 8-K 103, 3 38, 10-Q 25, SC 13G/A 23, SC 13G 17, 144 16, CORRESP 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TECX (0.002 USD), /gw/filings/filings?ticker=TECX&form=8-K, /gw/filings/facts?ticker=TECX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange